🔗 Permalink

Inventor profile of:

Michael R. Simon

City:

Ann Arbor, Michigan

Country:

United States

Published Applications:

Last publication date:

2025-10-23

Top Assignees for applications by Michael R. Simon

The entities that hold a legal rights for patent applications filed by inventor Simon Michael R.:

Michael R. Simon 2 Ann Arbor, MI United States
Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health 1 Washington, DC United States

Recent patent applications by Simon Michael R.

Michael R. Simon from Ann Arbor, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-23

US20250326821A1

Chemistry; metallurgy

PROCESS FOR PREPARATION OF SECRETORY IgA AND SECRETORY IgM AND USE THEREOF FOR TREATING NECROTIZING ENTEROCOLITIS

#2 | 2025-08-07

US20250249091A1

Human necessities

TREATMENT OF ALLERGY WITH DIMERIC IgA or SECRETORY IgA ANTIGEN IMMUNE COMPLEXES

#3 | 2024-09-12

US20240301036A1

Chemistry; metallurgy

TREATMENT OF INTESTINAL LUMEN IMMUNOGLOBULIN DEFICIENCY WITH SEMISYNTHETIC POLYCLONAL HUMAN SECRETORY IMMUNOGLOBIN A

#4 | 2024-03-21

US20240092940A1

Chemistry; metallurgy

TREATMENT OF NECROTIZING ENTEROCOLITIS WITH SEMISYNTHETIC POLYCLONAL HUMAN SECRETORY IMMUNOGLOBIN A

#5 | 2021-11-04

US20210340226A1

Chemistry; metallurgy

HUMAN MEDICAL PROPHYLAXIS OF CORONAVIRIDAE PATHOGENIC INFECTION BY TOPICAL APPLICATION OF IMMUNE CORONAVIRIDAE IMMUNOGLOBULIN A

#6 | 2020-04-09

US20200109185A1

Chemistry; metallurgy

Treatment of intestinal dysbiosis with immunoglobin

#7 | 2020-01-23

US20200022999A1

Human necessities

PLASMA CELL CYTOKINE VEHICLE CONTAINING FUSION PROTEINS FOR TARGETED INTRODUCTION OF SIRNA INTO CELLS AND TISSUES

#8 | 2019-08-22

US20190256577A1

Chemistry; metallurgy

Process for preparation of secretory IgA and secretory IgM

#9 | 2018-10-04

US20180280526A1

Human necessities

Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues

#10 | 2017-03-02

US20170058018A2

Chemistry; metallurgy

Process for preparation of secretory IgA and secretory IgM

#11 | 2016-11-03

US20160319039A1

Chemistry; metallurgy

Treatment of celiac disease, C. difficile infection, food intolerance and food allergy with secretory IgA/IgM

#12 | 2016-05-26

US20160145353A1

Chemistry; metallurgy

Treatment of food intolerance and food allergy with IgM

#13 | 2014-12-18

US20140371431A1

Chemistry; metallurgy

PROCESS FOR PREPARATION OF SECRETORY IgA AND SECRETORY IgM

#14 | 2014-11-27

US20140348935A1

Chemistry; metallurgy

Treatment of food intolerance and food allergy with IgM

#15 | 2014-08-21

US20140234961A1

Human necessities

SYNTHETIC SINGLE CHAIN VARIABLE DOMAIN (SCFV) IMMUNOGLOBULIN FRAGMENT VEHICLE CONTAINING FUSION PROTEINS FOR TARGETED INTRODUCTION OF siRNA

#16 | 2012-02-23

US20120045517A1

Chemistry; metallurgy

Treatment of celiac disease with IgA

#17 | 2011-12-15

US20110305753A1

Human necessities

Treatment of celiac disease with IgA

#18 | 2011-05-19

US20110117088A1

Human necessities

COMPOSITION AND METHOD FOR INTRODUCTION OF RNA INTERFERENCE SEQUENCES INTO TARGETED CELLS AND TISSUES

#19 | 2011-05-12

US20110110937A1

Human necessities

COMPOSITION AND METHOD FOR INTRODUCTION OF RNA INTERFERENCE SEQUENCES INTO TARGETED CELLS AND TISSUES

#20 | 2008-10-23

US20080260822A1

Chemistry; metallurgy

Synthesis of human secretory IgA and IgM and the formation of a medicament therefrom

#21 | 2008-06-19

US20080145420A1

Chemistry; metallurgy

HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES

#22 | 2008-06-19

US20080145371A1

Chemistry; metallurgy

Synthesis of human secretory IgA for the treatment of associated diseases

#23 | 2008-06-19

US20080145370A1

Human necessities

Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith

#24 | 2006-02-09

US20060030003A1

Chemistry; metallurgy

Composition and method for introduction of RNA interference sequences into targeted cells and tissues

#25 | 2005-11-24

US20050260214A1

Chemistry; metallurgy

Composition and method for introduction of RNA interference sequences into targeted cells and tissues

#26 | 2005-11-22

US10246158

Human medical treatment by aerosol inhalation of immunoglobulin A

#27 | 2005-11-17

US20050255120A1

Chemistry; metallurgy

Composition and method for introduction of DNA directed RNA interference sequences into targeted cells and tissues

#28 | 2005-08-23

US9815026

Human medical treatment by aerosol inhalation of immunoglobulin A

InventorID:

880136 ⎘